Gossamer Bio (GOSS) Short Interest Ratio & Short Volume → The CHIPS Act Motherlode (From True Market Insiders) (Ad) Free GOSS Stock Alerts $0.69 -0.04 (-5.45%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Gossamer Bio Short Interest DataCurrent Short Volume12,850,000 sharesPrevious Short Volume11,110,000 sharesChange Vs. Previous Month+15.66%Dollar Volume Sold Short$9.12 millionShort Interest Ratio / Days to Cover7.6Last Record DateApril 30, 2024Outstanding Shares226,220,000 sharesPercentage of Shares Shorted5.68%Today's Trading Volume972,256 sharesAverage Trading Volume2,110,871 sharesToday's Volume Vs. Average46% Short Selling Gossamer Bio ? Sign up to receive the latest short interest report for Gossamer Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatGOSS Short Interest Over TimeGOSS Days to Cover Over TimeGOSS Percentage of Float Shorted Over Time Ad True Market InsidersThe CHIPS Act MotherlodeIf you haven’t heard yet, the CHIPS Act is the US government pouring $280 BILLION into the manufacturing of US semiconductors. A lot of companies will make a fortune from this.Click here to see my #1 investment for 2024. Gossamer Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202412,850,000 shares $9.12 million +15.7%N/A7.6 $0.71 4/15/202411,110,000 shares $9.53 million +3.3%N/A8.5 $0.86 3/31/202410,760,000 shares $12.70 million -3.0%N/A8.7 $1.18 3/15/202411,090,000 shares $16.19 million -22.5%N/A10.3 $1.46 2/29/202414,300,000 shares $20.16 million -6.5%N/A11.2 $1.41 2/15/202415,300,000 shares $15.76 million -8.5%N/A11.1 $1.03 Get the Latest News and Ratings for GOSS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gossamer Bio and its competitors with MarketBeat's FREE daily newsletter. 1/31/202416,720,000 shares $14.04 million -3.6%N/A11.6 $0.84 1/15/202417,350,000 shares $16.89 million -1.2%N/A9.5 $0.97 12/31/202317,560,000 shares $16.02 million -6.7%N/A8.8 $0.91 12/15/202318,820,000 shares $19.20 million -16.7%N/A9.1 $1.02 11/30/202322,580,000 shares $17.66 million +1.9%N/A10.2 $0.78 11/15/202322,160,000 shares $17.97 million +10.6%N/A10.2 $0.81 10/31/202320,030,000 shares $10.02 million -14.6%N/A9.9 $0.50 10/15/202323,440,000 shares $15.14 million -1.7%N/A12.1 $0.65 9/30/202323,850,000 shares $19.86 million +18.2%N/A10.8 $0.83 9/15/202320,170,000 shares $18.56 million +2.0%N/A8.8 $0.92 8/31/202319,770,000 shares $20.56 million -3.3%N/A8.3 $1.04 8/15/202320,450,000 shares $23.31 million +1.6%N/A8.4 $1.14 7/31/202320,130,000 shares $27.18 million +37.2%34.3%8.1 $1.35 7/15/202314,670,000 shares $21.86 million +2.2%19.6%6.1 $1.49 6/30/202314,360,000 shares $17.23 million -11.6%19.2%6.7 $1.20 6/15/202316,250,000 shares $22.26 million +6.5%21.8%7.3 $1.37 5/31/202315,260,000 shares $20.45 million -3.2%20.5%5.2 $1.34 5/15/202315,770,000 shares $18.77 million -3.1%21.1%4.9 $1.19 4/30/202316,280,000 shares $21.00 million -5.0%23.4%5 $1.29 4/15/202317,130,000 shares $17.90 million +0.4%23.1%4.7 $1.05 3/31/202317,060,000 shares $21.50 million -30.4%23.0%4.4 $1.26 3/15/202324,520,000 shares $32.37 million -7.9%32.6%5.6 $1.32 2/28/202326,620,000 shares $46.05 million +5.4%35.6%4.5 $1.73 2/15/202325,250,000 shares $59.34 million -0.4%33.8%4.4 $2.35 1/31/202325,350,000 shares $66.92 million -6.7%35.8%4.5 $2.64 1/15/202327,170,000 shares $63.58 million +1.0%38.3%5.1 $2.34 12/30/202226,890,000 shares $58.35 million +86.6%38.0%5.5 $2.17 12/15/202214,410,000 shares $30.26 million -32.9%20.3%3.2 $2.10 11/30/202221,470,000 shares $183.78 million +12.2%30.4%7.4 $8.56 11/15/202219,130,000 shares $191.49 million +0.8%27.1%14.7 $10.01 10/31/202218,980,000 shares $210.68 million +7.5%N/A15.7 $11.10 10/15/202217,660,000 shares $214.92 million +1.7%N/A15.1 $12.17 9/30/202217,370,000 shares $208.09 million +4.6%24.0%11.2 $11.98 9/15/202216,610,000 shares $229.55 million +3.0%22.9%11.2 $13.82Man who spotted Apple at $1.49 says: “Buy These 6 AI Stocks.” (Ad)Man who spotted Apple at $1.49 says: "Buy These 6 AI Stocks."And these will be the biggest winners GOSS Short Interest - Frequently Asked Questions What is Gossamer Bio's current short interest? Short interest is the volume of Gossamer Bio shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 12,850,000 shares of GOSS short. Learn More on Gossamer Bio's current short interest. What is a good short interest ratio for Gossamer Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. GOSS shares currently have a short interest ratio of 8.0. Learn More on Gossamer Bio's short interest ratio. Is Gossamer Bio's short interest increasing or decreasing? Gossamer Bio saw a increase in short interest in April. As of April 30th, there was short interest totaling 12,850,000 shares, an increase of 15.7% from the previous total of 11,110,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Gossamer Bio's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Gossamer Bio: Rigel Pharmaceuticals, Inc. (3.23%), Capricor Therapeutics Inc (13.01%), Prelude Therapeutics Incorporated (2.43%), scPharmaceuticals Inc. (17.76%), ProQR Therapeutics (0.41%), Alimera Sciences, Inc. (0.23%), Repare Therapeutics Inc. (2.38%), Greenwich LifeSciences, Inc. (3.24%), Galectin Therapeutics Inc. (7.35%), CervoMed Inc. (1.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Gossamer Bio stock? Short selling GOSS is an investing strategy that aims to generate trading profit from Gossamer Bio as its price is falling. GOSS shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Gossamer Bio? A short squeeze for Gossamer Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of GOSS, which in turn drives the price of the stock up even further. How often is Gossamer Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including GOSS, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Rigel Pharmaceuticals Short Interest Data Capricor Therapeutics Short Interest Data Prelude Therapeutics Short Interest Data scPharmaceuticals Short Interest Data ProQR Therapeutics Short Interest Data Alimera Sciences Short Interest Data Repare Therapeutics Short Interest Data Greenwich LifeSciences Short Interest Data Galectin Therapeutics Short Interest Data CervoMed Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:GOSS) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersBuy this small stock before coming AI Tidal WaveChaikin AnalyticsCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingShocking $16T Elon Musk Crypto LeakCrypto 101 MediaForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressHow Biden has already won 2024Porter & CompanyExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersA letter is coming from the "Bureau of the Fiscal Service".Stansberry Research